Luquan Zhang

机构：Harbin Medical University, Third Affiliated Hospital of Harbin Medical University · ORCID：0000-0001-7681-2337

发表论文 29 篇 · 总被引 354 次 · h-index 9

代表论文

• Analysis of multiple programmed cell death-related prognostic genes and functional validations of necroptosis-associated genes in oesophageal squamous cell carcinoma (2023 · EBioMedicine · 被引 59)
• Neoadjuvant camrelizumab combined with paclitaxel and nedaplatin for locally advanced esophageal squamous cell carcinoma: a single-arm phase 2 study (cohort study) (2023 · International Journal of Surgery · 被引 45)
• Knock-down of microRNA miR-556-5p increases cisplatin-sensitivity in non-small cell lung cancer (NSCLC) via activating NLR family pyrin domain containing 3 (NLRP3)-mediated pyroptotic cell death (2021 · Bioengineered · 被引 39)
• Long Non-coding RNA SNHG16 Facilitates Esophageal Cancer Cell Proliferation and Self-renewal through the microRNA-802/PTCH1 Axis (2022 · Current Medicinal Chemistry · 被引 27)
• Response to neoadjuvant immune checkpoint inhibitors and chemotherapy in Chinese patients with esophageal squamous cell carcinoma: the role of tumor immune microenvironment (2022 · Cancer Immunology Immunotherapy · 被引 22)
• Development of a cuproptosis-related signature for prognosis prediction in lung adenocarcinoma based on WGCNA (2023 · Translational Lung Cancer Research · 被引 20)